BDBM50263102 (1-(3-ethoxyphenyl)-2-(2-fluorophenyl)-1H-imidazol-4-yl)(4-(naphthalen-2-yl)piperazin-1-yl)methanone::CHEMBL516355

SMILES CCOc1cccc(c1)-n1cc(nc1-c1ccccc1F)C(=O)N1CCN(CC1)c1ccc2ccccc2c1

InChI Key InChIKey=DMAAYJMSAAIEQW-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50263102   

TargetCholecystokinin receptor type A(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263102((1-(3-ethoxyphenyl)-2-(2-fluorophenyl)-1H-imidazol...)
Affinity DataIC50:  1.90nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263102((1-(3-ethoxyphenyl)-2-(2-fluorophenyl)-1H-imidazol...)
Affinity DataEC50:  6.30nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed